Sleep and muscle recovery: Endocrinological and molecular basis for a new and promising hypothesis

Medical Hypotheses

Volumn 77, Issue 2, 2011, Pages 220-222

  Dattilo, M ^b   Antunes, H K M ^a,b   Medeiros, A ^a   Monico Neto M ^b   Souza, H S ^b   Tufik, S ^a   De Mello, M T ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Centro de Estudos em Psicobiologia e Exercicio CEPE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ATROGIN 1; CORTICOSTERONE; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROCORTISONE; MAMMALIAN TARGET OF RAPAMYCIN; MUSLE RING FINGER 1 PROTEIN; MYOSTATIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; REGULATED IN DEVELOPMENT AND DNA DAMAGE RESPONSE 1 PROTEIN; SOMATOMEDIN C; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; CACHEXIA; CONVALESCENCE; HUMAN; HYPOTHESIS; MUSCLE ATROPHY; MUSCLE INJURY; MUSCLE MASS; MUSCLE METABOLISM; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SKELETAL MUSCLE; SLEEP; SLEEP DEPRIVATION;

ANIMALS; HUMANS; HYDROCORTISONE; INSULIN-LIKE GROWTH FACTOR I; MUSCULAR DISORDERS, ATROPHIC; PROTEIN BIOSYNTHESIS; PROTEOLYSIS; RATS; RECOVERY OF FUNCTION; SLEEP DEPRIVATION; TESTOSTERONE;

RATTUS;

EID: 79960646920     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.04.017     Document Type: Article

References (41)

1. Tufik S., Andersen M.L., Bittencourt L.R., Mello M.T. Paradoxical sleep deprivation: neurochemical, hormonal and behavioral alterations. Evidence from 30years of research. An Acad Bras Cienc 2009, 81:521-538.
2. Rial R.V., Nicolau M.C., Gamundí A., et al. The trivial function of sleep. Sleep Med Rev 2007, 11:311-325.
3. Goel N., Rao H., Durmer J.S., Dinges D.F. Neurocognitive consequences of sleep deprivation. Semin Neurol 2009, 29:320-339.
4. Santos R.V., Tufik S., De Mello M.T. Exercise, sleep and cytokines: is there a relation?. Sleep Med Rev 2007, 231-239.
5. Knutson K.L., Spiegel K., Penev P., Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007, 11:163-178.
6. Spiegel K., Leproult R., Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354:1435-1439.
7. Leproult R., Van Cauter E. Role of sleep and sleep loss in hormonal release and metabolism. Endocr Dev 2010, 17:11-21.
8. Hipólide D.C., Suchecki D., Pimentel de Carvalho Pinto A., Chiconelli Faria E., Tufik S., Luz J. Paradoxical sleep deprivation and sleep recovery: effects on the hypothalamic-pituitary-adrenal axis activity, energy balance and body composition of rats. J Neuroendocrinol 2006, 18:231-238.
9. Andersen M.L., Martins P.J., D'Almeida V., Bignotto M., Tufik S. Endocrinological and catecholaminergic alterations during sleep deprivation and recovery in male rats. J Sleep Res 2005, 14:83-90.
10. Everson C.A., Crowley W.R. Reductions in circulating anabolic hormones induced by sustained sleep deprivation in rats. Am J Physiol Endocrinol Metab 2004, 286:E1060-E1070.
11. Patel S.R. Reduced sleep as an obesity risk factor. Obes Rev 2009, 10:61-68.
12. Taheri S., Lin L., Austin D., Young T., Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004, 1:e62.
13. Spiegel K., Tasali E., Penev P., Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004, 141:846-850.
14. Martins P.J., Marques M.S., Tufik S., D'Almeida V. Orexin activation precedes increased NPY expression, hyperphagia, and metabolic changes in response to sleep deprivation. Am J Physiol Endocrinol Metab 2010, 298:E726-E734.
15. Balbo M., Leproult R., Van Cauter E. Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activity. Int J Endocrinol 2010, 759234. Epub 2010 June 9.
16. von Treuer K., Norman T.R., Armstrong S.M. Overnight human plasma melatonin, cortisol, prolactin, TSH, under conditions of normal sleep, sleep deprivation, and sleep recovery. J Pineal Res 1996, 20:7-14.
17. Weibel L., Follenius M., Spiegel K., Ehrhart J., Brandenberger G. Comparative effect of night and daytime sleep on the 24-hour cortisol secretory profile. Sleep 1995, 18:549-556.
18. Weitzman E.D., Zimmerman J.C., Czeisler C.A., Ronda J. Cortisol secretion is inhibited during sleep in normal man. J Clin Endocrinol Metab 1983, 56:352-358.
19. Luboshitzky R., Zabari Z., Shen-Orr Z., Herer P., Lavie P. Disruption of the nocturnal testosterone rhythm by sleep fragmentation in normal men. J Clin Endocrinol Metab 2001, 86:1134-1139.
20. Gambineri A., Pelusi C., Pasquali R. Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters. J Endocrinol Inves 2003, 26:493-498.
21. Kant G.J., Genser S.G., Thorne D.R., Pfalser J.L., Mougey E.H. Effects of 72hour sleep deprivation on urinary cortisol and indices of metabolism. Sleep 1984, 7:142-146.
22. Nedeltcheva A.V., Kilkus J.M., Imperial J., Schoeller D.A., Penev P.D. Insufficient sleep undermines dietary efforts to reduce adiposity. Ann Intern Med 2010, 153:435-441.
23. McKinnell I.W., Rudnicki M.A. Molecular mechanisms of muscle atrophy. Cell 2004, 119:907-910.
24. Sandri M. Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 2008, 23:160-170.
25. Bodine S.C., Stitt T.N., Gonzalez M., et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 2001, 3:1014-1019.
26. Shah O.J., Kimball S.R., Jefferson L.S. Glucocorticoids abate p70(S6k) and eIF4E function in L6 skeletal myoblasts. Am J Physiol Endocrinol Metab 2000, 279:E74-E82.
27. Proud C.G. Signalling to translation: how signal transduction pathways control the protein synthetic machinery. Biochem J 2007, 403:217-234.
28. Lang C.H., Frost R.A., Vary T.C. Regulation of muscle protein synthesis during sepsis and inflammation. Am J Physiol Endocrinol Metab 2007, 293:E453-E459.
29. Reiling J.H., Sabatini D.M. Stress and mTORture signaling. Oncogene 2006, 25:6373-6383.
30. Wu Y., Zhao W., Zhao J., et al. REDD1 is a major target of testosterone action in preventing dexamethasone-induced muscle loss. Endocrinology 2010, 151:1050-1059.
31. McPherron A.C., Lawler A.M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997, 387:83-90.
32. Joulia D., Bernardi H., Garandel V., Rabenoelina F., Vernus B., Cabello G. Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res 2003, 286:263-275.
33. Langley B., Thomas M., Bishop A., Sharma M., Gilmour S., Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 2002, 277:49831-49840.
34. Ríos R., Carneiro I., Arce V.M., Devesa J. Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol 2002, 282:C993-C999.
35. Kayali A.G., Young V.R., Goodman M.N. Sensitivity of myofibrillar proteins to glucocorticoid-induced muscle proteolysis. Am J Physiol 1987, 252:E621-E626.
36. Millward D.J., Garlick P.J., Nnanyelugo D.O., Waterlow J.C. The relative importance of muscle protein synthesis and breakdown in the regulation of muscle mass. Biochem J. 1976, 156:185-188.
37. Auclair D., Garrel D.R., Chaouki Zerouala A., Ferland L.H. Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids. Am J Physiol 1997, 272:C1007-C1016.
38. Jackman R.W., Kandarian S.C. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004, 287:C834-C843.
39. Pickart C.M. Mechanisms underlying ubiquitination. Annu Rev Biochem 2001, 70:503-533.
40. Wang H., Kubica N., Ellisen L.W., Jefferson L.S., Kimball S.R. Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1. J Biol Chem 2006, 281:39128-39134.
41. Richard-Bulteau H., Serrurier B., Crassous B., et al. Recovery of skeletal muscle mass after extensive injury: positive effects of increased contractile activity. Am J Physiol Cell Physiol 2008, 294:C467-C476.